UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical utility of circulating tumor DNA for colorectal cancer

Cancer science, 2019-04, Vol.110 (4), p.1148-1155

2019

Volltextzugriff (PDF)

Immunotherapy in Colorectal Cancer: Current and Future Strategies

Journal of the Anus, Rectum and Colon, 2021/01/28, Vol.5(1), pp.11-24

2021

Volltextzugriff (PDF)

Enrichment of CLDN18‐ARHGAP fusion gene in gastric cancers in young adults

Cancer science, 2019-04, Vol.110 (4), p.1352-1363

2019

Volltextzugriff (PDF)

BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation

Cancers, 2020-11, Vol.12 (11), p.3236

2020

Volltextzugriff (PDF)

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

Cancer science, 2022-03, Vol.113 (3), p.1057-1068

2022

Volltextzugriff (PDF)

Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-01, Vol.19 (1), p.183-191

2016

Volltextzugriff (PDF)

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer

Journal of gastroenterology, 2018-11, Vol.53 (11), p.1186-1195

2018

Volltextzugriff (PDF)

Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database

PloS one, 2021-02, Vol.16 (2), p.e0246160-e0246160

2021

Volltextzugriff (PDF)

REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

BMC cancer, 2021-06, Vol.21 (1), p.674-6, Article 674

2021

Volltextzugriff (PDF)

Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival

Cancer chemotherapy and pharmacology, 2020-02, Vol.85 (2), p.265-272

2020

Volltextzugriff (PDF)

Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research

International journal of clinical oncology, 2021-02, Vol.26 (2), p.335-344

2021

Volltextzugriff (PDF)

A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)

Annals of surgical oncology, 2020-10, Vol.27 (11), p.4188-4195

2020

Volltextzugriff (PDF)

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-05, Vol.22 (3), p.518-525

2019

Volltextzugriff (PDF)

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

BMC cancer, 2023-05, Vol.23 (1), p.401-401, Article 401

2023

Volltextzugriff (PDF)

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer

Cancer science, 2010-04, Vol.101 (4), p.1067-1071

2010

Volltextzugriff (PDF)

Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy

Nature communications, 2024-07, Vol.15 (1), p.5885-11, Article 5885

2024

Volltextzugriff (PDF)

KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1273-1283

2023

Volltextzugriff (PDF)

Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation

Cancers, 2023-02, Vol.15 (5), p.1473

2023

Volltextzugriff (PDF)

Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer

International journal of cancer, 2019-11, Vol.145 (9), p.2488-2495

2019

Volltextzugriff (PDF)

Druggable gene alterations in Japanese patients with rare malignancy

Neoplasia (New York, N.Y.), 2022-11, Vol.33, p.100834-100834, Article 100834

2022

Volltextzugriff (PDF)

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker

BMC cancer, 2018-04, Vol.18 (1), p.406-406, Article 406

2018

Volltextzugriff (PDF)

Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial): study protocol

BMJ open, 2022-09, Vol.12 (9), p.e063071

2022

Volltextzugriff (PDF)

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer

Cancer science, 2018-08, Vol.109 (8), p.2567-2575

2018

Volltextzugriff (PDF)

Outcomes of Surgical Treatment for Patients with Anorectal Malignant Melanoma; Results of Nine Cases in a Single Institution

Journal of the Anus, Rectum and Colon, 2021/04/28, Vol.5(2), pp.192-196

2021

Volltextzugriff (PDF)

1 – 25 von 471

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(395)
Mit Volltextzugriff
(396)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(219)
Life Sciences & Biomedicine
(189)
Humans
(147)
Male
(116)
Oncology
(109)
Female
(94)
Middle Aged
(90)
Aged
(88)
Adult
(78)
Colorectal Cancer
(70)
Chemotherapy
(62)
Metastasis
(51)
Patients
(50)
Medicine
(49)
Medicine & Public Health
(46)
Metastases
(43)
Colorectal Neoplasms - Drug Therapy
(42)
Mutation
(41)
Cancer
(38)
Colorectal Carcinoma
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Clinical utility of circulating tumor DNA for colorectal cancer

Immunotherapy in Colorectal Cancer: Current and Future Strategies

Enrichment of CLDN18‐ARHGAP fusion gene in gastric cancers in young adults

BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer

Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database

REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival

Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research

A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer

Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy

NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases

KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer

Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation

Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer

Druggable gene alterations in Japanese patients with rare malignancy

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker

Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial): study protocol

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer

Outcomes of Surgical Treatment for Patients with Anorectal Malignant Melanoma; Results of Nine Cases in a Single Institution

Suchergebnisse filtern